Fusion Antibodies Plc
(LSE) FAB
Fusion Antibodies Plc Financials at a Glance
Market Cap
$1.81B
Revenue (TTM)
$3.40M
Net Income (TTM)
$3.09M
EPS (TTM)
$-1.44
P/E Ratio
-10.07
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Price
$14.12
Volume
443,005
Open
$14.02
Price
$14.12
Volume
443,005
Open
$14.02
Previous Close
$14.12
Daily Range
$13.50 - $14.40
52-Week Range
$5.62 - $21.00
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Price
$14.12
Volume
443,005
Open
$14.02
Previous Close
$14.12
Daily Range
$13.50 - $14.40
52-Week Range
$5.62 - $21.00
FAB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fusion Antibodies Plc
Industry
Life Sciences Tools and Services
Sector
Health CareCEO
Adrian Kinkaid, PhD
Website
www.fusionantibodies.comHeadquarters
Belfast, BT17 0QL, GB
FAB Financials
Key Financial Metrics (TTM)
Gross Margin
18%
Operating Margin
-1%
Net Income Margin
-92%
Return on Equity
-164%
Return on Capital
-2%
Return on Assets
-81%
Earnings Yield
-9.93%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.81B
Shares Outstanding
125.02M
Volume
443.00K
Short Interest
0.00%
Avg. Volume
444.33K
Financials (TTM)
Gross Profit
$430.00K
Operating Income
$1.78M
EBITDA
$1.62M
Operating Cash Flow
$1.36M
Capital Expenditure
$10.00K
Free Cash Flow
$1.37M
Cash & ST Invst.
$359.00K
Total Debt
$20.00K
Fusion Antibodies Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$838.00K
+54.9%
Gross Profit
$185.00K
+188.5%
Gross Margin
22.08%
N/A
Market Cap
$1.81B
N/A
Market Cap/Employee
$67.14M
N/A
Employees
27
N/A
Net Income
$512.00K
+62.3%
EBITDA
$476.00K
+63.2%
Quarterly Fundamentals
Net Cash
$419.00K
-195.2%
Accounts Receivable
$868.00K
+8.9%
Inventory
$272.00K
-48.1%
Long Term Debt
$566.00K
+1786.7%
Short Term Debt
$105.00K
+517.6%
Return on Assets
-80.96%
N/A
Return on Invested Capital
-1.82%
N/A
Free Cash Flow
$635.00K
+53.0%
Operating Cash Flow
$575.00K
+57.5%